3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Burkitt Lymphoma
7
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Down Syndrome
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Lymphoma
1
Interventions
Whole-Body Irradiation
7
fludarabine
6
Mycophenolic Acid
6
Cyclophosphamide
6
fludarabine phosphate
5
Sirolimus
4
Cyclosporine
4
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
ibrutinib
2
acalabrutinib
2
Rituximab
2
Melphalan
2
venetoclax
1
treosulfan
1
tafasitamab
1
obinutuzumab
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Stem Cell Transplantation
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Ganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic
×
asparaginase erwinia chrysanthemi recombinant
×
1 year
×
Clear all
No trials found.